Rediscovering Langhans' Fibrinoid Layer: A Forgotten Barrier at the Maternal–Fetal Interface

Document Type : Letters to the Editor

Authors

1 Department of Anatomy, All India Institute of Medical Sciences, Bibinagar, Telangana, India

2 Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India

3 Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, India

Abstract
In placental histopathology, the Langhans' fibrinoid layer holds a unique but often overlooked position. Although it was described over a hundred years ago and featured in classic medical texts, it has gradually faded from modern research. Langhans' fibrinoid is one of the most underappreciated and inconsistently described parts of placental structure. In this article, we revisit its historical roots, anatomical ambiguity, and potential clinical significance, aiming to give it a clear and updated definition in current placental studies and diagnostics.

Keywords

Subjects


Copyright © 2026. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license also allows users to adapt, remix, transform, and build upon the material for any purpose, including commercial use.

1.        Boyd JD, Hamilton WJ. The Human Placenta. Cambridge: Heffer& Sons; 1970. [DOI:10.1007/978-1-349-02807-8]
2.        Schneider H, Moser RW. Classics revisited. RaissaNitabuch, on the uteroplacental circulation and the fibrinous membrane. Placenta. 2016;40:34-9. [DOI:10.1016/j.placenta.2016.02.011] [PMID]
3.        Burton GJ, Fowden AL. The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 2015;370:20140066. [DOI:10.1098/rstb.2014.0066] [PMID] [PMCID]
4.        Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452-7. [DOI:10.1016/j.ajog.2004.07.030] [PMID]
5.        Salafia CM, Charles AK, Maas EM. Placenta and fetal growth restriction. Clin Obstet Gynecol. 2006;49:236-56. [DOI:10.1097/00003081-200606000-00007] [PMID]
6.        van der Meeren LE, Krop J, Dijkstra KL, Bloemenkamp KWM, Cornish EF, Nikkels PGJ, van der Hoorn MP, Bos M. One-Sided Chronic Intervillositis of Unknown Etiology in Dizygotic Twins: A Description of 3 Cases. Int J Mol Sci. 2021;22:4786. [DOI:10.3390/ijms22094786] [PMID] [PMCID]
7.        Kim EN, Lee JY, Shim JY, Hwang D, Kim KC, Kim SR, Kim CJ. Clinicopathological characteristics of miscarriages featuring placental massive perivillous fibrin deposition. Placenta. 2019;86:45-51 [DOI:10.1016/j.placenta.2019.07.006] [PMID]
8.        Bos M, Harris-Mostert ETMS, van der Meeren LE, Baelde JJ, Williams DJ, Nikkels PGJ, et al. Clinical outcomes in chronic intervillositis of unknown etiology. Placenta. 2020;91:19-23. [DOI:10.1016/j.placenta.2020.01.001] [PMID]
9.        Huynh J, Dawson D, Roberts D, Bentley-Lewis R. A systematic review of placental pathology in maternal diabetes mellitus. Placenta. 2015;36:101-14. [DOI:10.1016/j.placenta.2014.11.021] [PMID] [PMCID]
10.     Jarmuzek P, Wielgos M, Bomba-Opon D. Placental pathologic changes in gestational diabetes mellitus. Neuro Endocrinol Lett. 2015;36:101-5.
Volume 21, Issue 1
Winter 2026
Pages 146-149

  • Receive Date 24 April 2025
  • Revise Date 05 June 2025
  • Accept Date 03 September 2025